Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel vs placebo in refractory partial-onset seizures (China)
CTR20131839Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2014
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perampanel in epilepsy, intractable epilepsy (IE), sponsored by Eisai Co., Ltd.. Started Jul 2014; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsyintractable epilepsy (IE)
Beyond the preview
Go deeper on CTR20131839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131839.